Optimizing for Luck in Drug Development Optimizing for Luck in Drug Development Continue readingOptimizing for Luck in Drug Development Comments closed
An Immuno-Oncology Target You’ve (Probably) Never Heard of – Releasing the Brakes on the Innate Immune System An Immuno-Oncology Target You’ve (Probably) Never Heard of – Releasing the Brakes on the Innate Immune System Continue readingAn Immuno-Oncology Target You’ve (Probably) Never Heard of – Releasing the Brakes on the Innate Immune System Comments closed
The Multiple Sclerosis Competitive Landscape The Multiple Sclerosis Competitive Landscape Continue readingThe Multiple Sclerosis Competitive Landscape Comments closed
Trillium Therapeutics: a Pure-Play on CD47 as an Immuno-Oncology Target Trillium Therapeutics: a Pure-Play on CD47 as an Immuno-Oncology Target Continue readingTrillium Therapeutics: a Pure-Play on CD47 as an Immuno-Oncology Target Comments closed
Small-Molecule Strategies Aimed at Degrading Cellular Proteins Small-Molecule Strategies Aimed at Degrading Cellular Proteins Continue readingSmall-Molecule Strategies Aimed at Degrading Cellular Proteins Comments closed
Strategies to Enhance Patient Responses to Checkpoint Inhibitors Strategies to Enhance Patient Responses to Checkpoint Inhibitors Continue readingStrategies to Enhance Patient Responses to Checkpoint Inhibitors Comments closed
Epizyme Provides Update on Tazemetostat (EPZ-6438) Phase I data Epizyme Provides Update on Tazemetostat (EPZ-6438) Phase I data Continue readingEpizyme Provides Update on Tazemetostat (EPZ-6438) Phase I data Comments closed
Epizyme Inc. and the Orphan Drug with Mainstream Potential Epizyme Inc. and the Orphan Drug with Mainstream Potential Continue readingEpizyme Inc. and the Orphan Drug with Mainstream Potential Comments closed
Chromatin as a Cancer Target – Part III: Chromatin Readers Chromatin as a Cancer Target – Part III: Chromatin Readers Continue readingChromatin as a Cancer Target – Part III: Chromatin Readers Comments closed
Chromatin as a Cancer Target – Part II: Chromatin Erasers Chromatin as a Cancer Target – Part II: Chromatin Erasers Continue readingChromatin as a Cancer Target – Part II: Chromatin Erasers Comments closed
Chromatin as a Cancer Target – Part I: Chromatin Writers Chromatin as a Cancer Target – Part I: Chromatin Writers Continue readingChromatin as a Cancer Target – Part I: Chromatin Writers Leave a Comment
